• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • All Features
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • Diary
    • NEWS
    • Reports
    Pharmaceuticals & Biotech.
    Sector
    Watch
    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 Jan 2026, 01:21PM
    Lupin, Zydus Lifesciences Among DRChoksey's Top Picks As Pharma Sector Braces For Q3  Check Full List
    Lupin, Zydus Lifesciences Among DRChoksey's Top Picks As Pharma Sector Braces For Q3 Check Full List
    NDTV Profit
    Other notable picks include Alembic Pharma which is expected to benefit from specialty optionality and margin improvement.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 Jan 2026, 12:00AM

    Q3FY26 Earnings Preview - Pharma and Healthcare

    buy
    Pharmaceuticals & Biotech.
    by Axis Direct
    Axis Direct
    Our Top Earnings Plays: Lupin, Biocon and Fortis.
    Copy LinkShare onShare on Share on Share on
    Alert  
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 05 Jan 2026

    Q3FY26E Pharmaceuticals Sector Preview

    buy
    Pharmaceuticals & Biotech.
    by Deven Choksey
    Deven Choksey
    For our pharma coverage universe, we expect Revenue to be largely steady at INR 644,525 mn in Q3FY26E, translating into 3.7% YoY growth and a marginal -0.3% QoQ.
    Copy LinkShare onShare on Share on Share on
    Alert  
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 01 Jan 2026
    Will Zaynich Drug's Fast-Track Review Speed Europe Approval?
    Will Zaynich Drug's Fast-Track Review Speed Europe Approval?
    NDTV Profit
    Wockhardt Group's Zaynich drug, a novel antibiotic combination of Zidebactum and Cefepime, has received fast-track review status from the European Medicines Agency (EMA) for the treatment of serious bacterial infections, including severe urinary infections, hospital-acquired pneumonia, and life-threatening blood infections.
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 31 Dec 2025
    US commits $480 mn to Ivory Coast health sector under 'America First' pact
    Business Standard
    The United States and Ivory Coast signed a health deal Tuesday requiring the U.S. to commit USD 480 million to the West African nation's health sector as part of America First global health funding pacts that mirror the Trump administration's foreign policy. The signing in Ivory Coast's capital of Abidjan covers areas such as HIV, malaria, maternal and child health, and global health security. It is the latest agreement the U.S. has entered with more than a dozen African countries, most of them hit by U.S. aid cuts, including Ivory Coast. U.S. aid cuts have crippled health systems across the developing world, including in Africa, where many countries relied on the funding for crucial programs, including those responding to outbreaks of disease. The new health pact is based on the principle of shared responsibility with Ivory Coast committing to provide up to 163 billion CFA francs (USD 292 million) by 2030, representing 60% of the overall commitment, according to Ivorian Prime...
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 17 Dec 2025
    Madhya Pradesh forms panel to probe HIV infection among 6 children
    Business Standard
    The Madhya Pradesh government has formed a six-member committee to investigate how six children suffering from blood disorder thalassemia, including four treated at a hospital in Satna, contracted HIV infection, officials said. Tarun Rathi, Commissioner of the Public Health and Medical Education Department, issued an order on Tuesday announcing the formation of the investigation team and directed it to submit a report within seven days. The six children in the age group of 12 to 15 were found to be HIV positive after suspected contaminated blood transfusions at the district hospitals in Satna, Jabalpur and elsewhere. The parents of one of them were also found to be infected, officials said on Tuesday. Satna Collector Satish Kumar S told reporters that these infection cases came to light between January and May this year, and all the victims are currently undergoing treatment. "Children suffering from thalassemia were receiving regular blood transfusions. Six of them were found to b
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 16 Dec 2025
    Odisha unveils Pharma, MedTech Policy 2025, eyes 25,000 crore investment
    Business Standard
    The Odisha government on Tuesday unveiled Pharmaceutical and Medical Devices Policy-2025, aiming to attract investment of Rs 25,000 crore and create 1 lakh jobs by 2030. Chief Minister Mohan Charan Majhi launched the new policy here at the Odisha Pharma Summit-2025 in the presence of Industries Minister Sampad Chandra Swain and senior government officers. Speaking on the occasion, Industries Department's Additional Chief Secretary Hemant Sharma said India imports about 85 per cent of medical devices from other countries, and there is a huge opportunity for this sector. As a lot of units of pharmaceutical and medical devices are expected to come up in the next five years, Odisha must make an attempt to become a part of this endeavour, Sharma said. Under the policy, the state offers a 50 per cent subsidy on concessional land cost for units employing more than 200 Odisha-domiciled skilled staff. The government also offered a 30 per cent capital subsidy on eligible plant and machinery
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 15 Dec 2025
    Biocon launches drugs for diabetes and obesity treatment in Netherlands
    Business Standard
    The Netherlands launch builds on Biocon's entry into the UK in February, where it received regulatory approval for liraglutide from the Medicines and Healthcare Products Regulatory Agency
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 08 Dec 2025, 02:12PM
    HIV-free for seven years after cancer treatment, and doctors are amazed
    Business Standard
    A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 mutation once seen as essential, shifting cure research
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    P
    Pharmaceuticals & Biotech.
    SECTOR | 05 Dec 2025
    From hugs to food to tattoos: Debunking 16 dangerous myths about HIV
    Business Standard
    From casual contact and mosquito bites to tattoos, pregnancy, PrEP, and treatment, specialists debunk the misconceptions that fuel stigma and delay diagnosis
    Copy LinkShare onShare on Share on Share on
    Deven Choksey released a Sector Update report for Pharmaceuticals & Biotech. on 05 Jan, 2026.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    • All Features
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Gabion Technologies
    • Yajur Fibres
    • Victory Electric Vehicles
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2026 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)